Everything We’re Saying, and Everything Being Said About Us
Explore the stories behind our science and the people it serves.
Subscribe to Our Monthly Newsletter
Each month, we will send key data updates, stories from the field, and new research on inclusive oncology AI.
PAICON Company Retreat Recap
Our recent company retreat at Strotzbüscher Mühle was a valuable experience for our team.
PAICON SatSight DX for Rapid MSI Detection in Colorectal Cancer
Microsatellite instability (MSI) is a critical biomarker in colorectal cancer (CRC), influencing diagnosis, prognosis, and treatment decisions. Traditional MSI detection...
PAICON Shines at Health.Tech 2024 with AI Solutions
Attending the Health.Tech Conference in Munich was a major milestone for PAICON.
PAICON Exhibited at DMEA 2024 in Berlin
Participating in DMEA Connecting Digital Health provided an exceptional opportunity for PAICON to engage with like-minded startups and companies dedicated...
Wrap-up: Keynote Lecture STMM Industry and Innovation Days
Our co-founder and managing director, Dr. Manasi Aichmueller-Ratnaparkhe, attended the STMM Industry and Innovation Days at the Heidelberg University as...
PAICON’s Partnership with UKHD and DKFZ
In an ever-evolving healthcare landscape, continuous collaboration is key to driving meaningful advancements.
EU AI Act Enacted: New Rules for AI Risk and Oversight
The EU AI Act, introduced in June 2023, is a significant milestone in regulating artificial intelligence within the European Union....
PAICON Exhibited at NLS 2023 in Copenhagen
PAICON stepped onto the stage at the Nordic Life Science Days on 29–30 November 2023, which is one of the...
Insights on Keynote Lecture at EuroSTEMPeers 2023
Dr. Manasi Aichmüller-Ratnaparkhe, co-founder of PAICON, was a featured speaker at EuroSTEMPeers on 3 June 2023, which is an influential...
Subscribe to Our Monthly Newsletter
Each month, we will send key data updates, stories from the field, and
new research on
inclusive oncology AI.
We respect your privacy. Unsubscribe at any time.